Simple Summary The authors report the most up-to-date review and a thorough meta-
analysis of inflammatory, immunological markers such as neutrophil-to-lymphocyte ratio …

Background Markers of systemic inflammation are correlated with patient survival in various
cancers. The prognostic value of neutrophil-to-lymphocyte ratio (NLR) was compared with …

Inflammation is related to cancer. The systemic immune-inflammation index (SII) has been
linked to the prognosis of many types of cancer. The present study aimed to determine the …

Background: Inflammation plays an important role in tumorigenesis. Previous studies have
reported the prognostic value of several peripheral inflammatory markers in glioma patients …

Neutrophil–lymphocyte ratio (NLR) is a hematological marker of systemic inflammation and
several studies demonstrate an association between a higher NLR and a worse prognosis …

Background Red cell distribution width (RDW), neutrophil–lymphocyte ratio (NLR), and
platelet count (PLT) routinely tested as part of the complete blood count are indicative of …

Objective Hematologic inflammatory markers are simple, inexpensive prognostic markers for
various conditions. The prognostic significance of the neutrophil-to-lymphocyte ratio (NLR) …

Background: Neutrophil–lymphocyte ratio (NLR) is a simple, low-cost and easily measured
inflammation marker, corresponding with pathological tumor grading and clinical prognosis …

Background. Systemic immunity and inflammation indexes (SI) derived from blood cells
have gained increasing attention in clinical oncology as potential biomarkers that are …

Glioma is the most common malignant brain tumor and has high lethality. This tumor
generated a robust inflammatory response that results in the deterioration of the disease …